Home › Biology

📖 3 min read

CYP2D6 gene duplication: how ancient diet shaped modern drug responses

The key finding

Dietary pressures over evolutionary time have driven the expansion of detoxification genes across species, fundamentally shaping how organisms—including humans—process both natural toxins and modern pharmaceuticals. In humans, duplications of the CYP2D6 gene enhance metabolism of alkaloids and drugs, a trait that appears to reflect ancient adaptations to plant-based diets. This pattern of dietary-driven gene expansion (DGE) is not unique to humans: tobacco-feeding aphids amplify the CYP6CY3 gene for nicotine resistance, and woodrats expand multiple absorption, distribution, metabolism, and excretion (ADME) genes to handle creosote-rich diets. These examples reveal that what ancient organisms ate has left a lasting genetic signature that influences drug responses and pesticide resistance today.

What the study looked like

This 2026 review synthesizes findings from comparative genomics studies across multiple species, examining patterns of gene duplication in detoxification pathways. The authors analyzed human CYP2D6 gene copy number variation alongside parallel examples from other species facing dietary challenges—aphids exposed to tobacco alkaloids and woodrats consuming creosote bush plants high in toxic resins. Rather than conducting new experiments, the paper integrates evidence from evolutionary biology, pharmacogenetics, and toxicology to identify common mechanisms. The focus is on ADME genes—those responsible for how organisms absorb, distribute, metabolize, and excrete chemical compounds—and how dietary selection pressures lead to amplification of these genes over generations.

Why researchers think this happened

The proposed mechanism centers on natural selection favoring individuals with extra gene copies when those copies confer survival advantages. For early humans consuming plant-heavy diets rich in alkaloids—nitrogen-containing compounds that plants produce as defensive toxins—having multiple copies of CYP2D6 would have enabled faster detoxification, reducing poisoning risk and expanding available food sources. Over time, populations with higher copy numbers survived and reproduced more successfully. The same logic applies to aphids feeding on nicotine-laden tobacco: insects with amplified CYP6CY3 genes can tolerate higher toxin loads, outcompeting those without duplications. Woodrats demonstrate the breadth of this pattern by expanding not just one but several ADME genes simultaneously to handle the chemically complex creosote bush diet. This convergent evolution across distant species suggests that dietary toxin exposure is a powerful and repeatable driver of genomic change.

How to read this carefully

This is a broad evolutionary synthesis rather than a controlled experimental study, so causation is inferred from patterns rather than directly tested. The human CYP2D6 findings reflect population-level correlations between gene copy number and geographic or dietary history—not individual diet interventions. The link between ancient plant consumption and modern gene frequencies remains a hypothesis supported by indirect evidence. Additionally, CYP2D6 copy number varies widely among individuals and populations, influenced by multiple evolutionary pressures beyond diet alone. The examples from aphids and woodrats strengthen the general principle but do not prove the specific dietary triggers for human gene duplications. Readers should understand this as a framework for interpreting genomic diversity, not a definitive account of every duplication event.

What this means for everyday life

This research helps explain why people respond so differently to the same medications—differences that pharmacogenetic testing now tries to predict. If you’ve ever had an unexpected reaction to an antidepressant, opioid painkiller, or beta-blocker, your CYP2D6 copy number may be part of the reason: some people have none, others have up to thirteen copies. Given this evolutionary backstory, it might be worth considering pharmacogenetic testing before starting drugs known to be CYP2D6 substrates, especially if you’ve had unusual medication responses in the past. The findings also underscore that genetic variation is not random noise but often reflects deep adaptive history. What your ancestors ate thousands of years ago shaped the enzymes you carry today—a reminder that evolutionary biology and personalized medicine are more connected than they might first appear.


Source

  • PMID: 41074839 (read full paper on PubMed)
  • Journal: Clinical pharmacology and therapeutics (2026)

Articles on this site are adapted from PubMed abstracts as general-interest explainers. They are not intended as medical advice.

📝 This article was adapted by the PubMed Trivia editorial team using Claude (Anthropic) as an adaptation assistant, based on the PubMed abstract cited above. Our editorial workflow includes automated NG-term checks (medical-claims law), careful "correlation vs causation" distinction, and mandatory PMID + source URL disclosure. See the full pipeline on our editorial policy and editor pages. Please report errors to sciencepubmedjp@gmail.com (we respond within 48 hours).